These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34545749)

  • 1. The effects of sex on pharmacogenetically guided drug treatment.
    Mezzalira S; Toffoli G
    Pharmacogenomics; 2021 Oct; 22(15):959-962. PubMed ID: 34545749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics: Chasing Perfection.
    Gaedigk A
    Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
    La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En route to precision medicine through the integration of biological sex into pharmacogenomics.
    Gaignebet L; Kararigas G
    Clin Sci (Lond); 2017 Feb; 131(4):329-342. PubMed ID: 28159880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
    Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
    Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
    Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
    Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
    [No Abstract]   [Full Text] [Related]  

  • 12. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Databases in the area of pharmacogenetics.
    Sim SC; Altman RB; Ingelman-Sundberg M
    Hum Mutat; 2011 May; 32(5):526-31. PubMed ID: 21309040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 15. Could pharmacogenetics aid the prediction of nevirapine pharmacokinetics and allow individualized treatment?
    Kwara A
    Pharmacogenomics; 2021 Sep; 22(14):881-884. PubMed ID: 34505542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation.
    Scott SA; Swen JJ
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33801919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice.
    Yalcin N; Allegaert K
    Mol Genet Metab; 2022; 137(1-2):210-212. PubMed ID: 36152474
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated in a systems pharmacology approach, pharmacogenetics holds the promise for personalized medicine in neonates.
    Allegaert K
    Pharmacogenomics; 2022 Aug; 23(12):667-670. PubMed ID: 35929406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic potential in advanced cancer patients.
    Nichols D; Arnold S; Weiss HL; Wu J; Durbin EB; Miller R; Kolesar J
    Am J Health Syst Pharm; 2019 Mar; 76(7):415-423. PubMed ID: 31361818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.